长非编码RNA在肝细胞癌内索拉芬尼抗性的新兴作用
Puneet Vij1, Mohammad Shabir Hussain2,3, Sanjaya K Satapathy4
1Department of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, USA.
Cancers
|December 17, 2024
概括
肝细胞癌 (HCC) 患者通常会对常见的肝癌药物Sorafenib产生耐药性. 本综述探讨了长非编码RNA (lncRNAs) 如何促进这种耐药性,为潜在的治疗策略提供了见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肝细胞癌 (HCC) 是全球流行的一种癌症.
- 索拉芬尼是晚期HCC的关键治疗方法,但耐药性很常见.
- 长非编码RNAs (lncRNAs) 与癌症的发展和耐药性有关.
研究的目的:
- 审查HCC中Sorafenib耐药性的分子机制.
- 探索 lncRNAs 在 Sorafenib 耐药性中的作用.
- 确定与lncRNAs相关的潜在治疗点.
主要方法:
- 对HCC,索拉费尼布耐药性和lncRNAs的研究进行文献综述.
- 分析药物耐药性所涉及的分子通路.
- 综合目前对HCC中lncRNA功能的理解.
主要成果:
- 索拉费尼布耐药性涉及多种机制,包括药物运输和信号通路的改变.
- lncRNAs在调节这些抵抗机制方面发挥着重要作用.
- 特定的lncRNA与用Sorafenib治疗的HCK患者的预后不佳有关.
结论:
- 了解 lncRNA 介导的机制对于克服 HCC.Sorafenib 耐药性至关重要.
- 向lncRNAs为HCC治疗提供了一个有前途的治疗途径.
- 需要进一步的研究来阐明特定的lncRNA功能,并开发有针对性的疗法.
关键词:
欧洲农业基金会 (EGFR) 是一个.索拉费尼布的耐药性 索拉费尼布的耐药性在VEGFA中,VEGFA是VEGFA.自自是自的过程.肝细胞癌 (HCC) 是一种肝细胞癌.长非编码RNA (LncRNA) 是一种长非编码RNA.蛋白质组学 蛋白质组学细胞癌 (RCC) 是一种细胞癌.更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Types of RNA
5.6K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.6K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
